DA Davidson added Herbalife (HLF) to the firm’s “Stampede list” while keeping a Buy rating on the shares with a $14 price target Herbalife is showing signs of turnaround under the new incoming CEO, who has taken actions to re-ignite distributor engagement, upgrade digital capabilities, and acquire technologies, the analyst tells investors in a research note. The firm says new distributors, which is a leading indicator of sales, were up double-digits in the last three quarters. Despite a deleveraged balance sheet and positive free cash flow, the stock “remains deeply discounted,” contends DA.